20 results
8-K
EX-10.1
LGVN
Longeveron Inc - Ordinary Shares
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
8-K
EX-10.1
LGVN
Longeveron Inc - Ordinary Shares
22 Dec 23
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:44am
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
8-K
EX-10.1
2opj03 zi09wze
13 Oct 23
Longeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:00am
424B3
o2fwxv55zm02ijf
22 Dec 21
Prospectus supplement
5:07pm
8-K
EX-10.1
o815r l2s
3 Dec 21
Longeveron Inc. Announces Pricing of a $20.5 Million Private Placement
5:13pm
10-K
1kk7n37zr29 ilq
30 Mar 21
Annual report
4:51pm
424B4
3ojgbios0k82i
12 Feb 21
Prospectus supplement with pricing info
4:09pm
S-1
EX-10.2
lsdxs
19 Jan 21
IPO registration
5:21pm
S-1
EX-10.1
2rqdth8dhnrc2y5p nb
19 Jan 21
IPO registration
5:21pm
S-1
jxn7zk
19 Jan 21
IPO registration
5:21pm
DRS/A
mgzuj50kwuka7i
30 Dec 20
Draft registration statement (amended)
12:00am
DRS
gjvb194t
12 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next